Joan Figuerola

783 total citations
22 papers, 475 citations indexed

About

Joan Figuerola is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Joan Figuerola has authored 22 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 10 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Joan Figuerola's work include Tracheal and airway disorders (8 papers), Respiratory viral infections research (6 papers) and Neonatal Respiratory Health Research (6 papers). Joan Figuerola is often cited by papers focused on Tracheal and airway disorders (8 papers), Respiratory viral infections research (6 papers) and Neonatal Respiratory Health Research (6 papers). Joan Figuerola collaborates with scholars based in Spain, United States and Australia. Joan Figuerola's co-authors include Jordi Reina, Daniel Hervás, Juan A. Hervás, José M. González del Valle, Aina M. Yáñez, Carla López-Causapé, Antonio Oliver, Gabriel Cabot, Borja Osona and Alain A. Ocampo-Sosa and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PEDIATRICS.

In The Last Decade

Joan Figuerola

22 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan Figuerola Spain 11 228 197 150 117 69 22 475
T. Pressler Denmark 13 406 1.8× 76 0.4× 86 0.6× 179 1.5× 62 0.9× 28 614
Adelaida Lamas Spain 11 260 1.1× 100 0.5× 64 0.4× 178 1.5× 26 0.4× 24 539
Simon C Langton Hewer United Kingdom 10 389 1.7× 101 0.5× 82 0.5× 122 1.0× 61 0.9× 23 531
G. Döering Germany 8 490 2.1× 169 0.9× 83 0.6× 266 2.3× 25 0.4× 14 630
Héctor Escobar Spain 12 272 1.2× 200 1.0× 28 0.2× 92 0.8× 85 1.2× 33 578
A Equi United Kingdom 6 421 1.8× 176 0.9× 56 0.4× 92 0.8× 29 0.4× 7 541
J. Maddison United Kingdom 7 429 1.9× 96 0.5× 97 0.6× 128 1.1× 22 0.3× 10 562
Margaret Kloster United States 15 604 2.6× 125 0.6× 39 0.3× 80 0.7× 42 0.6× 26 685
A. Scarcella Italy 12 54 0.2× 156 0.8× 157 1.0× 63 0.5× 47 0.7× 17 517
David Heaf United Kingdom 7 352 1.5× 54 0.3× 157 1.0× 165 1.4× 23 0.3× 11 488

Countries citing papers authored by Joan Figuerola

Since Specialization
Citations

This map shows the geographic impact of Joan Figuerola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Figuerola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Figuerola more than expected).

Fields of papers citing papers by Joan Figuerola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Figuerola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Figuerola. The network helps show where Joan Figuerola may publish in the future.

Co-authorship network of co-authors of Joan Figuerola

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Figuerola. A scholar is included among the top collaborators of Joan Figuerola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Figuerola. Joan Figuerola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agyeman, Akosua Adom, Carla López-Causapé, Kate E. Rogers, et al.. (2023). Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity. International Journal of Antimicrobial Agents. 62(3). 106887–106887. 10 indexed citations
2.
Osona, Borja, Guillem Frontera, Joan Figuerola, et al.. (2021). High flow nasal cannula versus standard low flow nasal oxygen during flexible bronchoscopy in children: A randomized controlled trial. Pediatric Pulmonology. 56(12). 4001–4010. 20 indexed citations
3.
Osona, Borja, et al.. (2021). Diagnosis and management of aspiration using fiberoptic endoscopic evaluation of swallowing in a Pediatric Pulmonology Unit. Pediatric Pulmonology. 56(6). 1651–1658. 2 indexed citations
4.
Osona, Borja, et al.. (2020). Long-term outcomes of necrotizing pneumonia. SHILAP Revista de lepidopterología. 95(5). 298–306. 7 indexed citations
5.
Osona, Borja, et al.. (2020). Resultados a largo plazo de la neumonía necrotizante. Anales de Pediatría. 95(5). 298–306. 4 indexed citations
6.
Figuerola, Joan, et al.. (2019). Utility of fiberoptic bronchoscopy for difficult airway in neonates. The Journal of Maternal-Fetal & Neonatal Medicine. 34(16). 2754–2757. 5 indexed citations
7.
Osona, Borja, et al.. (2018). Neonatal swallowing assessment using fiberoptic endoscopic evaluation of swallowing (FEES). Pediatric Pulmonology. 53(4). 437–442. 26 indexed citations
8.
López-Causapé, Carla, Lea M. Sommer, Gabriel Cabot, et al.. (2017). Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone. Scientific Reports. 7(1). 5555–5555. 109 indexed citations
9.
Peña, Mónica de la, Aina M. Yáñez, Josep Miquel Bauçà, et al.. (2017). Glycated hemoglobin and sleep apnea syndrome in children: beyond the apnea–hypopnea index. Sleep And Breathing. 22(1). 205–210. 5 indexed citations
10.
Osona, Borja, et al.. (2016). Hypoxia Challenge Testing in Neonates for Fitness to Fly. PEDIATRICS. 137(3). e20152915–e20152915. 9 indexed citations
11.
Bauçà, Josep Miquel, et al.. (2015). Assessing the improvements in the newborn screening strategy for cystic fibrosis in the Balearic Islands. Clinical Biochemistry. 48(6). 419–424. 5 indexed citations
12.
Pérez‐Yarza, E.G., Antonio Moreno, Octavio Ramilo, et al.. (2015). Risk factors for bronchiolitis, recurrent wheezing, and related hospitalization in preterm infants during the first year of life. Pediatric Allergy and Immunology. 26(8). 797–804. 21 indexed citations
13.
López-Causapé, Carla, Estrella Rojo‐Molinero, Xavier Mulet, et al.. (2013). Clonal Dissemination, Emergence of Mutator Lineages and Antibiotic Resistance Evolution in Pseudomonas aeruginosa Cystic Fibrosis Chronic Lung Infection. PLoS ONE. 8(8). e71001–e71001. 56 indexed citations
14.
Osona, Borja, et al.. (2012). Exhaled Nitric Oxide in Acute Phase of Bronchiolitis and Its Relation with Episodes of Subsequent Wheezing in Children of Preschool Age. Pediatric Allergy Immunology and Pulmonology. 25(2). 92–96. 8 indexed citations
15.
Hervás, Daniel, Jordi Reina, Aina M. Yáñez, et al.. (2012). Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis. European Journal of Clinical Microbiology & Infectious Diseases. 31(8). 1975–1981. 111 indexed citations
16.
Hervás, Daniel, et al.. (2010). How frequent is varicella-associated pneumonia in children?. European Journal of Clinical Microbiology & Infectious Diseases. 30(3). 435–437. 12 indexed citations
17.
Hervás, Daniel, et al.. (2008). RISK OF VARICELLA COMPLICATIONS IN CHILDREN TREATED WITH INHALED STEROIDS. The Pediatric Infectious Disease Journal. 27(12). 1113–1114. 2 indexed citations
18.
Reina, Jordi, et al.. (2008). Características clínicas y epidemiológicas de las infecciones respiratorias causadas por el metapneumovirus humano en pacientes pediátricos. Enfermedades Infecciosas y Microbiología Clínica. 26(2). 72–76. 4 indexed citations
20.
Juliá, María Rosa, Catalina Crespı́, Joan Figuerola, et al.. (2003). γδ T lymphocytes from cystic fibrosis patients and healthy donors are high TNF-α and IFN-γ-producers in response to Pseudomonas aeruginosa. Respiratory Research. 4(1). 9–9. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026